CASI Pharmaceuticals, Inc. (CASI)

CASI Pharmaceuticals Statistics

Total Valuation

CASI has a market cap or net worth of $32.53 million. The enterprise value is $16.44 million.

Market Cap	32.53M
Enterprise Value	16.44M

Important Dates

The last earnings date was Monday, March 31, 2025, before market open.

Earnings Date	Mar 31, 2025
Ex-Dividend Date	n/a

Share Statistics

CASI has 15.49 million shares outstanding. The number of shares has increased by 14.82% in one year.

Current Share Class	15.49M
Shares Outstanding	15.49M
Shares Change (YoY)	+14.82%
Shares Change (QoQ)	+25.22%
Owned by Insiders (%)	5.00%
Owned by Institutions (%)	2.54%
Float	7.85M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	1.16
Forward PS	4.31
PB Ratio	18.56
P/TBV Ratio	20.17
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	0.58
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.09

Current Ratio	1.09
Quick Ratio	0.86
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-45.02

Financial Efficiency

Return on equity (ROE) is -301.80% and return on invested capital (ROIC) is -103.72%.

Return on Equity (ROE)	-301.80%
Return on Assets (ROA)	-38.01%
Return on Invested Capital (ROIC)	-103.72%
Return on Capital Employed (ROCE)	-227.69%
Revenue Per Employee	$162,142
Profits Per Employee	-$223,057
Employee Count	176
Asset Turnover	0.44
Inventory Turnover	1.65

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -40.17% in the last 52 weeks. The beta is 0.61, so CASI's price volatility has been lower than the market average.

Beta (5Y)	0.61
52-Week Price Change	-40.17%
50-Day Moving Average	2.37
200-Day Moving Average	4.53
Relative Strength Index (RSI)	44.63
Average Volume (20 Days)	8,488

Short Selling Information

The latest short interest is 23,246, so 0.15% of the outstanding shares have been sold short.

Short Interest	23,246
Short Previous Month	27,388
Short % of Shares Out	0.15%
Short % of Float	0.30%
Short Ratio (days to cover)	2.36

Income Statement

In the last 12 months, CASI had revenue of $28.54 million and -$39.26 million in losses. Loss per share was -$2.56.

Revenue	28.54M
Gross Profit	11.15M
Operating Income	-39.21M
Pretax Income	-27.02M
Net Income	-39.26M
EBITDA	-36.88M
EBIT	-39.21M
Loss Per Share	-$2.56

Balance Sheet

The company has $16.09 million in cash and n/a in debt, giving a net cash position of $16.09 million or $1.04 per share.

Cash & Cash Equivalents	16.09M
Total Debt	n/a
Net Cash	16.09M
Net Cash Per Share	$1.04
Equity (Book Value)	1.85M
Book Value Per Share	0.12
Working Capital	3.12M

Cash Flow

In the last 12 months, operating cash flow was -$29.22 million and capital expenditures -$223,000, giving a free cash flow of -$29.45 million.

Operating Cash Flow	-29.22M
Capital Expenditures	-223,000
Free Cash Flow	-29.45M
FCF Per Share	-$1.90

Margins

Gross margin is 39.06%, with operating and profit margins of -137.41% and -137.57%.

Gross Margin	39.06%
Operating Margin	-137.41%
Pretax Margin	-137.57%
Profit Margin	-137.57%
EBITDA Margin	-129.24%
EBIT Margin	-137.41%
FCF Margin	n/a

Dividends & Yields

CASI does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-14.82%
Shareholder Yield	-14.82%
Earnings Yield	-120.67%
FCF Yield	-90.51%

Analyst Forecast

The average price target for CASI is $6.00, which is 185.71% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$6.00
Price Target Difference	185.71%
Analyst Consensus	Strong Buy
Analyst Count	1
Revenue Growth Forecast (5Y)	21.92%
EPS Growth Forecast (5Y)	n/a

Stock Splits

The last stock split was on June 2, 2022. It was a reverse split with a ratio of 0.1:1.

Last Split Date	Jun 2, 2022
Split Type	Reverse
Split Ratio	0.1:1

Scores

Altman Z-Score	n/a
Piotroski F-Score	1